Kinase insert domain receptor
Kinase insert domain receptor (KDR), also known as vascular endothelial growth factor receptor 2 (VEGFR-2), is a vascular endothelial growth factor (VEGF) receptor. KDR is a type of receptor tyrosine kinase (RTK) that is predominantly expressed in endothelial cells and plays a crucial role in angiogenesis and vasculogenesis.
Structure[edit | edit source]
The KDR protein is a transmembrane receptor composed of seven immunoglobulin-like domains in the extracellular domain, a single transmembrane spanning region, and a cytoplasmic tyrosine kinase domain split by a kinase-insert domain. The kinase insert domain is unique to KDR and other related receptors, hence the name "kinase insert domain receptor".
Function[edit | edit source]
KDR is a key mediator of VEGF-induced endothelial proliferation, survival, and migration and tubulogenesis. It is also a cellular receptor for macrophage-stimulating protein (MSP) which upon binding induces its dimerization and autophosphorylation.
Clinical significance[edit | edit source]
Mutations in KDR gene are associated with infantile capillary hemangiomas. In addition, KDR/VEGFR-2 is a major target for anti-angiogenic drug therapy in cancer treatment.
See also[edit | edit source]
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD